Hepsor AS (TAL:HPR1T)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	26	16	27	35	52	-
Market Cap Growth	4.58%	-40.29%	-23.08%	-32.59%	-	-
Enterprise Value	68	68	70	78	75	-
Last Close Price	6.72	4.01	6.71	8.73	12.95	-
PE Ratio	14.98	38.09	22.77	25.13	-	-
Forward PE	-	10.93	10.93	10.93	-	-
PS Ratio	0.50	0.42	0.66	2.73	3.48	-
PB Ratio	1.28	0.73	1.22	1.73	2.73	-
P/TBV Ratio	1.36	0.77	1.29	1.77	2.75	-
P/FCF Ratio	-	1.81	-	-	-	-
P/OCF Ratio	-	1.81	-	-	-	-
EV/Sales Ratio	1.29	1.77	1.70	6.09	5.00	-
EV/EBITDA Ratio	10.11	15.59	13.80	309.63	39.00	-
EV/EBIT Ratio	10.34	15.71	13.91	361.00	39.77	-
EV/FCF Ratio	-	7.66	-	-	-	-
Debt / Equity Ratio	2.13	2.49	2.57	2.40	1.50	1.74
Debt / EBITDA Ratio	6.49	12.10	10.90	133.04	14.02	4.62
Debt / FCF Ratio	-	6.18	-	-	-	1.44
Asset Turnover	0.61	0.43	0.49	0.19	0.35	1.15
Inventory Turnover	0.63	0.45	0.46	0.21	0.40	1.27
Quick Ratio	0.27	0.22	0.16	0.15	0.89	0.53
Current Ratio	3.75	2.33	1.72	2.54	4.15	3.53
Return on Equity (ROE)	19.10%	9.66%	16.38%	6.76%	12.14%	47.35%
Return on Assets (ROA)	4.73%	3.01%	3.72%	0.20%	2.74%	6.37%
Return on Capital (ROIC)	5.57%	3.47%	4.25%	0.23%	3.19%	7.56%
Return on Capital Employed (ROCE)	10.70%	7.40%	12.40%	0.40%	4.40%	15.40%
Earnings Yield	6.67%	2.63%	4.39%	3.98%	-0.04%	-
FCF Yield	-	55.15%	-1.94%	-81.85%	-18.13%	-
Dividend Yield	3.78%	6.49%	-	-	-	-
Buyback Yield / Dilution	-1.64%	-	-	-23.39%	-4.14%	-
Total Shareholder Return	2.14%	6.49%	-	-23.39%	-4.14%	-

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.